PERFIL EPIDEMIOLÓGICO DO LABORATÓRIO DE HEMODINÂMICA DO HOSPITAL SÃO LUCAS
DOI:
https://doi.org/10.61164/rmnm.v6i1.2405Keywords:
Hemodynamics. Risk Factors. Cardiology. Epidemiological Profile.Abstract
The prevalence of cardiovascular diseases is a public health issue that affects about 30% of the adult population worldwide, according to the World Health Organization (WHO). In addition to this, there has also been an increase in indications for cardiovascular procedures and the need for the improvement of modern and minimally invasive techniques such as the hemodynamic intervention method. This method is a safe and effective option for both diagnosis and therapy for patients undergoing cardiology procedures. Considering the relevance of these data, the objective of this research is to assess the epidemiological profile for cardiovascular diseases, associated risk factors, and the relationship of catheterization indications in a specific population.
References
American Heart Association, American College of Cardiology, American College of Chest Physicians, American Society for Preventive Cardiology, National Lipid Association, & Preventive Cardiovascular Nurses Association. (2023). 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.
Berry, J. D., Dyer, A., Cai, X., et al. (2012). Lifetime risks of cardiovascular disease. New England Journal of Medicine, 366, 321-329.
Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Análise em Saúde e Vigilância de Doenças Não Transmissíveis. (2021). Plano de Ações Estratégicas para o Enfrentamento das Doenças Crônicas e Agravos não Transmissíveis no Brasil 2021- 2030 [recurso eletrônico]. Brasília: Ministério da Saúde.
Collaboration, N. R. F. Worldwide trends in diabetes since 1980: pooled analysis of 751 population-based measurement studies with over 4.4 million participants.
Collins, R., Reith, C., Emberson, J., et al. (2016). Interpretation of the evidence for the efficacy and safety of statin therapy. The Lancet, 388, 2532–2561.
Feijó, M. K. E. F. (2007). Prevalência de fatores de risco para doença arterial coronariana em pacientes submetidos a procedimentos cardíacos invasivos em unidade de hemodinâmica [Monografia]. Porto Alegre: Escola de Enfermagem, Universidade Federal do Rio Grande do Sul.
Feres, F., Costa, R. A., Siqueira, D., Costa, J. R., Chamié, D., Staico, R., ... et al. (2017). Diretriz da Sociedade Brasileira de Cardiologia e da Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista sobre intervenção coronária percutânea. Arq Bras Cardiol, 109(Suppl 1), 1-81.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: A systematic analysis for the global burden of disease study 2015. The Lancet, 388, 1545–1602.
Global Cardiovascular Risk Consortium. (2023). Global effect of modifiable risk factors on cardiovascular disease and mortality. New England Journal of Medicine, 389(14), 1273-1285.
Gus, I., Fischmann, A., & Medina, C. (2002). Prevalência dos fatores de risco da doença arterial coronariana no Estado do Rio Grande do Sul. Arquivos Brasileiros de Cardiologia, 78(5), 478-483.
Hannan, E. L., Samadashvili, Z., Cozzens, K., Walford, G., Jacobs, A. K., Holmes, D. R. Jr., et al. (2012). Comparative outcomes for patients who do and do not undergo percutaneous coronary intervention for stable coronary artery disease in New York. Circulation, 125:1870.
Hemerly, M. B., Siman, A. G., Paiva, A. C. P. C., Ribeiro, L., Amaro, M. O. F., Carneiro, N. S., & Diaz, F. B. B. S. (2019). Perfil dos pacientes submetidos ao cateterismo cardíaco. Revista Saúde Coletiva, 09(N.49).
International Diabetes Federation. (2021). IDF Diabetes Atlas, 10th edn. Brussels, Belgium.
Jaspers, N. E. M., Blaha, M. J., Matsushita, K., et al. (2020). Prediction of individualized lifetime benefit from lowering blood pressure, antithrombotic therapy, and smoking cessation in apparently healthy people. European Heart Journal, 41, 1190-1199.
Joseph, P., Leong, D., McKee, M., Anand, S. S., Schwalm, J. D., Teo, K., ... & Yusuf, S. (2017). Reducing the global burden of cardiovascular disease, part 1: the epidemiology and risk factors. Circulation research, 121(6), 677-694.
Leong, D. P., Joseph, P. G., McKee, M., Anand, S. S., Te o, K. K., Schwalm, J. D., & Yusuf, S. (2017). Reducing the global burden of cardiovascular disease, part 2: prevention and treatment of cardiovascular disease. Circulation research, 121(6), 695-710.
McQueen, M. J., Hawken, S., Wang, X., Ounpuu, S., Sniderman, A., Probstfield, J., ... Yusuf, S. (2008). Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (INTERHEART study): A case-control study. The Lancet, 372(9634), 224–233.
Micha, R., Michas, G., & Mozaffarian, D. (2012). Unprocessed red and processed meats and risk of coronary artery disease and type 2 diabetes–an updated review of the evidence. Current Atherosclerosis Reports, 14, 515–524.
Organização Mundial da Saúde (OMS). (2011). Atlas Global de Prevenção e Controle de Doenças Cardiovasculares. Genebra: OMS.
Organização Pan-Americana de Saúde. (2017, maio). Doenças cardiovasculares. [Internet].
Prospective Studies Collaboration, Lewington, S., Whitlock, G., Clarke, R., Sherliker, P., Emberson, J., Halsey, J., Qizilbash, N., Peto, R., & Collins, R. (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet (London, England), 370(9602), 1829–1839.
Sociedade de Cardiologia do Estado do Rio de Janeiro (SOCERJ). (2023). Manual de Promoção da Saúde Cardiovascular Completo. Sociedade de Cardiologia do Estado do Rio de Janeiro.
Walli-Attaei, M., Joseph, P., Rosengren, A., et al. (2020). Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet, 396, 97-109.
World Health Organization. (2013). Global action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization.
Zhou, B., Carrillo-Larco, R. M., Danaei, G., Riley, L. M., Paciorek, C. J., Stevens, G. A., ... & Breckenkamp, J. (2021). Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. The Lancet, 398(10304), 957-980.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Revista Multidisciplinar do Nordeste Mineiro
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
